Munich-based smartbax, a biotech developing antibiotics against multi-drug resistant bacteria, has announced the in-licensing ...
The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections ...
Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against ...
The field of cancer biology has witnessed rapid advances in our understanding of microRNAs (miRNAs) as crucial regulators of ...
AZoLifeSciences on MSN
Backyard soil bacterium produces antibiotic built to outsmart resistance
Early in 2025, scientists discovered a promising new antibiotic in a soil sample from a lab technician's backyard.
While resistance is a natural evolutionary process, the review shows that human activity has dramatically intensified its ...
Trade Brains on MSN
Rs145 to Rs1,397: What made this pharma stock deliver 861% returns in less than 3 yrs?
Wockhardt, once ranked among India's top pharmaceutical companies, has delivered a stunning revival. After a brutal near 93 ...
Early in 2025, scientists discovered a promising new antibiotic in a soil sample from a lab technician's backyard. The ...
Vermicomposting earthworms help turn manure into organic fertilizer, representing a potential tool against antibiotic ...
A global DNA deep dive shows why E. coli infections in diabetic foot wounds can be so stubborn, dangerous, and hard to treat.
New research led by King's College London, in collaboration with the University of Westminster, has shed light on the ...
Antimicrobial resistance (AMR) threatens the effectiveness of standard anti-infective drugs and calls for therapeutic concepts that can bypass, disable, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results